title: Reply: Modifying the Poor Prognosis Associated with 18F-FDG-Avid NET with Peptide Receptor Chemo-Radionuclide Therapy (PRCRT).
authors.affiliation: University of Rennes, CS 44229 Rennes F-35042, France E-mail: e.garin@rennes.unicancer.fr.
authors.forename: Etienne
authors.initials: E
authors.lastname: Garin
authors.affiliation: University of Rennes, CS 44229 Rennes F-35042, France E-mail: e.garin@rennes.unicancer.fr.
authors.forename: Julien
authors.initials: J
authors.lastname: Edeline
mesh_terms: D005260:Female; D019788:Fluorodeoxyglucose F18; D006801:Humans; D007414:Intestinal Neoplasms / Q000000981:diagnostic imaging*; D008297:Male; D018358:Neuroendocrine Tumors / Q000000981:diagnostic imaging*; D010190:Pancreatic Neoplasms / Q000000981:diagnostic imaging*; D049268:Positron-Emission Tomography; D013274:Stomach Neoplasms / Q000000981:diagnostic imaging*
chemical_list: D019788:Fluorodeoxyglucose F18